iThyroid.com

LUTEIN

Following is a study mentioning that lutein may help macular degeneration.

 

Invest Ophthalmol Vis Sci 2001 Feb;42(2):439-446

Macular Pigment and Risk for Age-Related Macular Degeneration in Subjects from a Northern European Population.

Beatty S, Murray IJ, Henson DB, Carden D, Koh HH, Boulton ME

University Department of Ophthalmology, Manchester Royal Eye Hospital, Manchester. Visual Sciences Laboratory, Department of Optometry and Neuroscience, University of Manchester Institute of Science and Technology, Manchester. Department of Optometry and Vision Sciences, Cardiff University, United Kingdom.

[Record supplied by publisher]

PURPOSE. Age and advanced disease in the fellow eye are the two most important risk factors for age-related macular degeneration (AMD). In this study, the authors investigated the relationship between these variables and the optical density of macular pigment (MP) in a group of subjects from a northern European population. METHODS. The optical density of MP was measured psychophysically in 46 subjects ranging in age from 21 to 81 years with healthy maculae and in 9 healthy eyes known to be at high-risk of AMD because of advanced disease in the fellow eye. Each eye in the latter group was matched with a control eye on the basis of variables believed to be associated with the optical density of MP (iris color, gender, smoking habits, age, and lens density). RESULTS. There was an age-related decline in the optical density of macular pigment among volunteers with no ocular disease (right eye: r(2) = 0.29, P: = 0.0006; left eye: r(2) = 0.29, P: < 0.0001). Healthy eyes predisposed to AMD had significantly less MP than healthy eyes at no such risk (Wilcoxon's signed rank test: P: = 0.015). CONCLUSIONS. The two most important risk factors for AMD are associated with a relative absence of MP. These findings are consistent with the hypothesis that supplemental lutein and zeaxanthin may delay, avert, or modify the course of this disease.